Evidence map›Paper›PMID 40312148›Full record

SynthesisPhysiological reports2025

Ventilatory efficiency in cardiac amyloidosis-A systematic review and meta-analysis.

Robin Willixhofer, Elisabetta Salvioni, Nicolò Capra, Mauro Contini, Jeness Campodonico, Piergiuseppe Agostoni

Abstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Robin WillixhoferCentro Cardiologico Monzino, IRCCS, Milan, Italy.
Elisabetta SalvioniCentro Cardiologico Monzino, IRCCS, Milan, Italy.
Nicolò CapraCento Cardiologico Monzino, L'unita di Biostatistica, IRCCS, Milan, Italy.
Mauro ContiniCentro Cardiologico Monzino, IRCCS, Milan, Italy.
Jeness CampodonicoCentro Cardiologico Monzino, IRCCS, Milan, Italy.
Piergiuseppe AgostoniCentro Cardiologico Monzino, IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0002-8345-6382

Funding

Fondazione IEO-MONZINOItalian Ministry of Health B43C24000090001
6 · The paper itself

Abstract

In cardiac amyloidosis (CA) cardiopulmonary exercise testing (CPET) is underexplored. This study evaluated exercise limitations in CA using CPET, focusing on the ventilation-to-carbon dioxide production (VE/VCO

Indexed as

AmyloidosisCardiomyopathiesPulmonary VentilationCarbon DioxideExercise TestHumansOxygen ConsumptionCarbon Dioxideamyloidosiscardiomyopathyexercise testingheart failurerisk prediction

Identifiers

PMID40312148
PMCPMC12045699

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.